XML 68 R56.htm IDEA: XBRL DOCUMENT v3.20.4

Note 9 - Fair Value Considerations (Details Textual) shares in Thousands			1 Months Ended	3 Months Ended		6 Months Ended		12 Months Ended
	Mar. 31, 2020 USD ($) shares	Feb. 14, 2020 USD ($) shares	Nov. 30, 2021 USD ($)	Dec. 31, 2020 USD ($)	Dec. 31, 2019 USD ($)	Dec. 31, 2020 USD ($)	Dec. 31, 2019 USD ($)	Jun. 30, 2020 USD ($)	Nov. 02, 2018 USD ($)	Jun. 11, 2018 USD ($)
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability				$ 3,313,656		$ 2,411,333
Gain (Loss) from Change in Fair Value of CVR						(899,987)
Tuzistra XR [Member]
Business Combination, Contingent Consideration, Liability, Total				15,800,000		15,800,000			$ 8,800,000
Tuzistra XR [Member] | Forecast [Member]
Payment for Contingent Consideration Liability, Operating Activities			$ 3,000,000
ZolpiMist [Member]
Business Combination, Contingent Consideration, Liability, Total				300,000		300,000				$ 2,600,000
Innovus Pharmaceuticals [Member]
Business Combination, Contingent Consideration, Liability, Total		$ 200,000
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability				15,000	15,000	28,000	28,000
Business Combination, Contingent Value Rights, Maximum Range of Outcomes		$ 16,000,000
Business Combination, Maximum Shares to be Issued to Settle CVR (in shares) | shares		470
Stock Issued During Period, Shares, Contingent Value Rights (in shares) | shares	120
Stock Issued During Period, Value, Contingent Value Rights	$ 2,000,000
Business Combination, Contingent Value Rights, First Revenue Milestone	24,000,000
Gain (Loss) from Change in Fair Value of CVR	$ 300,000			$ (100,000)	$ (100,000)	$ (800,000)	$ (800,000)	$ 300,000
Innovus Pharmaceuticals [Member] | Measurement Input, Discount Rate [Member]
Business Combination, Contingent Consideration, Liability, Measurement Input		0.3

X

- Definition

The first revenue milestone for contingent value rights of the business acquisition.

+ References

No definition available.

+ Details

Name:	aytu_BusinessCombinationContingentValueRightsFirstRevenueMilestone
Namespace Prefix:	aytu_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

X

- Definition

The maximum amount of contingent value rights of the business combination.

+ References

No definition available.

+ Details

Name:	aytu_BusinessCombinationContingentValueRightsMaximumRangeOfOutcomes
Namespace Prefix:	aytu_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

X

- Definition

The maximum number of shares that would be issued to settle the contingent value rights issued in the business acquisition.

+ References

No definition available.

+ Details

Name:	aytu_BusinessCombinationMaximumSharesToBeIssuedToSettleCVR
Namespace Prefix:	aytu_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The amount of gain (loss) from change in fair value of CVR.

+ References

No definition available.

+ Details

Name:	aytu_GainLossFromChangeInFairValueOfCVR
Namespace Prefix:	aytu_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

The number of shares of stock issued during the period for contingent value rights.

+ References

No definition available.

+ Details

Name:	aytu_StockIssuedDuringPeriodSharesContingentValueRights
Namespace Prefix:	aytu_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The value of stock issued during the period for contingent value rights.

+ References

No definition available.

+ Details

Name:	aytu_StockIssuedDuringPeriodValueContingentValueRights
Namespace Prefix:	aytu_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 4
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=120321790&loc=d3e7008-128479

+ Details

Name:	us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Definition

Amount of liability recognized arising from contingent consideration in a business combination.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 35
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 25
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476

+ Details

Name:	us-gaap_BusinessCombinationContingentConsiderationLiability
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

X

- Definition

Value of input used to measure contingent consideration liability from business combination.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (bbb)(2)
-URI http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258

+ Details

Name:	us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput
Namespace Prefix:	us-gaap_
Data Type:	xbrli:decimalItemType
Balance Type:	na
Period Type:	instant

X

- Definition

Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability exceeding amount recognized at acquisition date. Includes, but is not limited to, measurement period adjustment and less amount paid soon after acquisition date.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 17
-Subparagraph (ee)
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585

+ Details

Name:	us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Details

Name:	us-gaap_BusinessAcquisitionAxis=aytu_TuzistraXrMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_StatementScenarioAxis=srt_ScenarioForecastMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_BusinessAcquisitionAxis=aytu_ZolpimistMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_BusinessAcquisitionAxis=aytu_InnovusPharmaceuticalsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: